Sanofi and Orano join forces to develop next-generationradioligand medicines

Press Release – Paris, October 17, 2024. Sanofi and Orano Med, a subsidiary of the Orano Group and a pioneer in the development of targeted alphatherapies in oncology, have entered into an agreement to combine their expertise in the fight against rare cancers and further accelerate the development of next-generation radioligand medicines. Building on the expertise and radioligand pipeline of Orano Med, Sanofi and Orano will … Continue reading Sanofi and Orano join forces to develop next-generationradioligand medicines

Impact Newswire17/10/202417/10/2024

United States

NSF Welcomes Mel Cash as Chief Commercial Officer

October 14, 2024 Global public health and safety organization announces new Commercial lead to drive growth and innovation. ANN ARBOR, Mich – NSF, a leading global public health and safety organization, has named Melissa (Mel) Cash its Vice President and Chief Commercial Officer. In this role, Cash will be responsible for accelerating growth across NSF’s global markets through commercial go-to-market strategies, sales enablement, brand awareness, program … Continue reading NSF Welcomes Mel Cash as Chief Commercial Officer

Impact Newswire16/10/202416/10/2024

Global

GE HealthCare to Lead Consortium on Synthetic Data Generation for AI in Healthcare

Chicago — October 13, 2024 — GE HealthCare will take a leadership role in Synthia, a consortium project to evaluate synthetic data generation methods, both for the creation of synthetic datasets and for their use in the development of artificial intelligence (AI) algorithms. GE Healthcare will join other healthcare industry organizations including Gates Ventures, NovoNordisk, and Pfizer and we well as academic partners including La … Continue reading GE HealthCare to Lead Consortium on Synthetic Data Generation for AI in Healthcare

Impact Newswire15/10/202415/10/2024

United States

Centra Board Appoints Richard Tugman As Permanent President & CEO

LYNCHBURG, Va., October 10, 2024–The Centra Board of Directors is pleased to announce that effective Oct. 7, Richard Tugman is appointed President & CEO of Centra Health. During an interim period in the role, Richard demonstrated the strong leadership necessary for guiding a complex health system. “Richard’s performance since his appointment in March 2024 as Interim President & CEO, in addition to his leadership in … Continue reading Centra Board Appoints Richard Tugman As Permanent President & CEO

Impact Newswire12/10/202412/10/2024

United States

Sonrava Health Welcomes Back Preet Takkar as President and Chief Operating Officer

October 08, 2024 – COPPELL, Texas – Sonrava Health is proud to announce that Preet Takkar has rejoined the organization as President and Chief Operating Officer. With over 20 years of experience in the dental industry, Takkar brings with him a wealth of knowledge and leadership that will be pivotal to the next phase of Sonrava Health’s growth. Preet Takkar is no stranger to the … Continue reading Sonrava Health Welcomes Back Preet Takkar as President and Chief Operating Officer

Impact Newswire10/10/202410/10/2024

Global

GE HealthCare accelerates artificial intelligence adoption with new offering to advance enterprise imaging

Oct 09, 2024 Integrated feature from Blackford offers AI-enabled decision support to help radiologists adapt to higher workloads and increased exam complexity. Chicago — October 9, 2024 — GE HealthCare integrates third party artificial intelligence (AI)-enabled application orchestration feature into True PACS and Centricity PACS. 1 In collaboration with Blackford, the new AI-enabled offerings help radiologists with their workload which could help lead to quicker diagnosis and treatment … Continue reading GE HealthCare accelerates artificial intelligence adoption with new offering to advance enterprise imaging

Impact Newswire10/10/202410/10/2024

United States

VMG Health Acquires Carnahan Group, Healthcare Consulting Firm

October 09, 2024 – DALLAS – VMG Health, the leading consulting firm for healthcare business performance, is pleased to announce its acquisition of Carnahan Group, a consulting firm dedicated to transforming healthcare with innovative technology. Based in Tampa, FL, Carnahan Group will fully integrate with VMG Health’s Physician Compensation and Strategic Consulting divisions, adding its automated platforms to the firm’s comprehensive suite of solutions. VMG Health … Continue reading VMG Health Acquires Carnahan Group, Healthcare Consulting Firm

Impact Newswire09/10/202409/10/2024

United States

Judo Bio Launches with $100 Million Financing to Develop Oligonucleotide Therapies Delivered to the Kidney and Appoints Rajiv Patni as CEO

STRIKE platform to deliver siRNA and other genetic medicines to the kidney for the treatment of systemic diseases and renal diseases Lead pipeline programs use megalin receptors for intracellular delivery of ligand-siRNA conjugates to specific kidney cells to target and silence genes, including solute carrier proteins CAMBRIDGE, Mass., October 7, 2024 — Judo Bio, a biotechnology company pioneering oligonucleotide medicines delivered to the kidney, today announced … Continue reading Judo Bio Launches with $100 Million Financing to Develop Oligonucleotide Therapies Delivered to the Kidney and Appoints Rajiv Patni as CEO

Impact Newswire08/10/202408/10/2024

United States

Iridex Appoints Patrick Mercer as Chief Executive Officer

MOUNTAIN VIEW, Calif., Oct. 03, 2024 (GLOBE NEWSWIRE) — Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and procedure probes for the treatment of glaucoma and retinal diseases, today announced the appointment of Patrick Mercer as the Company’s Chief Executive Officer and President effective October 1, 2024. Previously Mr. Mercer served as the Company’s Chief Operating Officer and President. David Bruce, the Company’s prior Chief Executive … Continue reading Iridex Appoints Patrick Mercer as Chief Executive Officer

Impact Newswire07/10/202407/10/2024